2014 Pharmaceutical manufacturing Physicians Retail 
World of DTC Marketing
AUGUST 12, 2022
Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The online retailer spends about $20 billion a year on R&D, despite being renowned for low prices and low profits.
pharmaphorum
OCTOBER 26, 2022
The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We This design will enable physicians to take more informed and robust treatment decisions than in most other cases,” Chiesi said. He serves as a Board Member on the Board of the Chiesi Group.
Expert insights. Personalized for you.
255 
Let's personalize your content